Analyst Recommendations

Benchmark analyst issues BUY recommendation for APPF on April 24, 2026 11:45AM ET. The previous analyst recommendation was Buy.APPF was trading at $152.3 at issue of the analyst...

April 24, 2026   APPF -5.89%

Morgan Stanley analyst issues OVERWEIGHT recommendation for MPC on April 24, 2026 10:13AM ET. The previous analyst recommendation was Overweight.MPC was trading at $221.1 at issue of the...

April 24, 2026   MPC -2.34%

Wolfe Research analyst issues OUTPERFORM recommendation for TMHC on April 23, 2026 02:57PM ET. The previous analyst recommendation was Outperform.TMHC was trading at $64.07 at issue of the...

April 23, 2026   TMHC -0.35%

RBC Capital analyst issues OUTPERFORM recommendation for TMHC on April 23, 2026 12:26PM ET. The previous analyst recommendation was Outperform.TMHC was trading at $65 at issue of the...

April 23, 2026   TMHC -0.35%

Cowen & Co. analyst issues BUY recommendation for LRCX on April 23, 2026 12:29PM ET. The previous analyst recommendation was Buy.LRCX was trading at $265.55 at issue of...

April 23, 2026   LRCX 1.38%

RBC Capital analyst issues OUTPERFORM recommendation for LRCX on April 23, 2026 12:49PM ET. The previous analyst recommendation was Outperform.LRCX was trading at $265.55 at issue of the...

April 23, 2026   LRCX 1.38%

Goldman Sachs analyst issues BUY recommendation for LRCX on April 23, 2026 11:08AM ET. The previous analyst recommendation was Buy.LRCX was trading at $265.55 at issue of the...

April 23, 2026   LRCX 1.38%

Susquehanna analyst issues NEUTRAL recommendation for MAR on April 23, 2026 11:36AM ET. The previous analyst recommendation was Neutral.MAR was trading at $367.13 at issue of the analyst...

April 23, 2026   MAR -1.13%

Citigroup analyst issues BUY recommendation for LRCX on April 23, 2026 11:54AM ET. The previous analyst recommendation was Buy.LRCX was trading at $265.55 at issue of the analyst...

April 23, 2026   LRCX 1.38%

Barclays analyst issues OVERWEIGHT recommendation for TMHC on April 23, 2026 10:23AM ET. The previous analyst recommendation was Overweight.TMHC was trading at $65 at issue of the analyst...

April 23, 2026   TMHC -0.35%